KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Change in Taxes (2016 - 2026)

Amgen has reported Change in Taxes over the past 18 years, most recently at $71.0 million for Q1 2026.

  • For Q1 2026, Change in Taxes fell 31.73% year-over-year to $71.0 million; the TTM value through Mar 2026 reached -$2.1 billion, down 85.93%, while the annual FY2025 figure was -$2.1 billion, 104.55% down from the prior year.
  • Change in Taxes for Q1 2026 was $71.0 million at Amgen, up from -$365.0 million in the prior quarter.
  • Over five years, Change in Taxes peaked at $610.0 million in Q3 2025 and troughed at -$2.4 billion in Q2 2025.
  • A 5-year average of -$275.6 million and a median of $71.0 million in 2026 define the central range for Change in Taxes.
  • Biggest five-year swings in Change in Taxes: skyrocketed 511.54% in 2022 and later plummeted 5578.57% in 2024.
  • Year by year, Change in Taxes stood at -$155.0 million in 2022, then crashed by 1209.03% to -$2.0 billion in 2023, then soared by 102.61% to $53.0 million in 2024, then crashed by 788.68% to -$365.0 million in 2025, then soared by 119.45% to $71.0 million in 2026.
  • Business Quant data shows Change in Taxes for AMGN at $71.0 million in Q1 2026, -$365.0 million in Q4 2025, and $610.0 million in Q3 2025.